GENPACT LIMITED

Genpact's 10.55 P/E sits conspicuously cheap relative to the broader management consulting space, yet the RSI of 38.3 suggests the stock hasn't even reached oversold territory despite underperformance. With a $5.8B market cap and only 7.31% short interest, there's minimal squeeze potential or capitulation signal. The absence of proximity to 52-week highs indicates a stock trapped in a downtrend without panic selling to reverse it. This valuation discount may reflect operational headwinds or sector rotation rather than a gift—the fundamentals require scrutiny before assuming mean reversion is imminent.